FR2930943B1 - Nouvelles utilisations de derives de d-mannopyranose inhibiteurs de l'angiogenese - Google Patents

Nouvelles utilisations de derives de d-mannopyranose inhibiteurs de l'angiogenese

Info

Publication number
FR2930943B1
FR2930943B1 FR0802537A FR0802537A FR2930943B1 FR 2930943 B1 FR2930943 B1 FR 2930943B1 FR 0802537 A FR0802537 A FR 0802537A FR 0802537 A FR0802537 A FR 0802537A FR 2930943 B1 FR2930943 B1 FR 2930943B1
Authority
FR
France
Prior art keywords
mannopyranosis
angiogenesis
novel uses
derivatives inhibitors
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0802537A
Other languages
English (en)
Other versions
FR2930943A1 (fr
Inventor
Jean Louis Montero
Veronique Montero
Jean Pierre Moles
Santa Barbara Pascal De
Caroline Clavel
Bernard Jover
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Original Assignee
Centre National de la Recherche Scientifique CNRS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS filed Critical Centre National de la Recherche Scientifique CNRS
Priority to FR0802537A priority Critical patent/FR2930943B1/fr
Priority to PCT/FR2009/000525 priority patent/WO2009138601A2/fr
Priority to JP2011507963A priority patent/JP2011520803A/ja
Priority to US12/991,631 priority patent/US20110112044A1/en
Priority to EP09745920A priority patent/EP2280985A2/fr
Priority to CA2723768A priority patent/CA2723768A1/fr
Publication of FR2930943A1 publication Critical patent/FR2930943A1/fr
Application granted granted Critical
Publication of FR2930943B1 publication Critical patent/FR2930943B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
    • C07H11/04—Phosphates; Phosphites; Polyphosphates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/12—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by acids having the group -X-C(=X)-X-, or halides thereof, in which each X means nitrogen, oxygen, sulfur, selenium or tellurium, e.g. carbonic acid, carbamic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
    • C07H7/02—Acyclic radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
FR0802537A 2008-05-07 2008-05-07 Nouvelles utilisations de derives de d-mannopyranose inhibiteurs de l'angiogenese Expired - Fee Related FR2930943B1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR0802537A FR2930943B1 (fr) 2008-05-07 2008-05-07 Nouvelles utilisations de derives de d-mannopyranose inhibiteurs de l'angiogenese
PCT/FR2009/000525 WO2009138601A2 (fr) 2008-05-07 2009-05-05 Nouvelles utilisations de derives de d-mannopyranose
JP2011507963A JP2011520803A (ja) 2008-05-07 2009-05-05 Ｄ−マンノピラノース誘導体
US12/991,631 US20110112044A1 (en) 2008-05-07 2009-05-05 Novel uses of d-mannopyranose derivatives
EP09745920A EP2280985A2 (fr) 2008-05-07 2009-05-05 Utilisation de derives de mannose-6-phosphate pour le contrôle de l'angiogénèse et la regénération ligamentaire et la reconstruction de cartilage
CA2723768A CA2723768A1 (fr) 2008-05-07 2009-05-05 Nouvelles utilisations de derives de d-mannopyranose

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0802537A FR2930943B1 (fr) 2008-05-07 2008-05-07 Nouvelles utilisations de derives de d-mannopyranose inhibiteurs de l'angiogenese

Publications (2)

Publication Number Publication Date
FR2930943A1 FR2930943A1 (fr) 2009-11-13
FR2930943B1 true FR2930943B1 (fr) 2011-03-18

Family

ID=40336799

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0802537A Expired - Fee Related FR2930943B1 (fr) 2008-05-07 2008-05-07 Nouvelles utilisations de derives de d-mannopyranose inhibiteurs de l'angiogenese

Country Status (6)

Country Link
US (1) US20110112044A1 (fr)
EP (1) EP2280985A2 (fr)
JP (1) JP2011520803A (fr)
CA (1) CA2723768A1 (fr)
FR (1) FR2930943B1 (fr)
WO (1) WO2009138601A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ596419A (en) 2009-04-28 2014-01-31 Pharmaxis Ltd Phosphotetrahydropyran compounds for the treatment of wounds and fibrotic disorders
CN103601767B (zh) * 2013-11-03 2016-06-29 大连九信生物化工科技有限公司 一种4,6-二羟基保护的葡萄吡喃己糖衍生物的脱保护方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9116896D0 (en) * 1991-08-06 1991-09-18 Erba Carlo Spa 3-deoxymannosamine derivatives and process for their preparation
WO2006002332A1 (fr) * 2004-06-23 2006-01-05 Angiotech Biomaterials Corporation Reparation des cartilages: methodes et compositions polymeres reticulees
US20080057072A1 (en) * 2006-08-31 2008-03-06 Alcon Manufacturing, Ltd. Antagonists of ci-m6p/igf2r for prevention and treatment of ctgf-mediated ocular disorders

Also Published As

Publication number Publication date
EP2280985A2 (fr) 2011-02-09
JP2011520803A (ja) 2011-07-21
WO2009138601A3 (fr) 2010-03-04
WO2009138601A2 (fr) 2009-11-19
US20110112044A1 (en) 2011-05-12
FR2930943A1 (fr) 2009-11-13
CA2723768A1 (fr) 2009-11-19

Similar Documents

Publication Publication Date Title
FR19C1033I2 (fr) Derives phosphores servant d'inhibiteurs de kinase
FR20C1027I2 (fr) Derives de tiglien-3-one
DOP2007000084A (es) Derivados de dihidropirazolopirimidinona
BRPI0907563A2 (pt) Derivados de 4,5-di-hidro-xazol-2-il amina
ATE478064T1 (de) Als pi-3-kinaseinhibitoren verwendete pyrimidinderivate
ATE496029T1 (de) Derivate von 1-phenyl-2-pyridinylalkylenalkohole als phosphodiesteraseinhibitoren
CR10400A (es) Derivados de lactamas de ciclohexilpirazol como inhibidores de 11-beta -hidroxiesteroide deshidrogenasa 1
CR10562A (es) Nuevos derivados de piridazina
SMT201400009B (it) Derivati eteroaromatici di ariltriazolo come inibitori dell'enzima pde 10A
ATE496051T1 (de) Pyrazolotetrahydropyridinderivate als orexinrezeptorantagonisten
ATE549340T1 (de) Spiroindolinon-derivate als mdm2-p53 inhibitoren
DE602006019624D1 (de) Piperidin-4-yl-pyridazin-3-yl-aminderivate als schnell dissoziierende antagonisten des dopamin-2-rezeptors
BRPI0715617A2 (pt) Derivados do ácido fenoxifenilacético 4-substituído
SMT201400114B (it) Derivati di 2-arilimidazolo come inibitori dell'enzima pde10a
DE602006010508D1 (de) Substituierte triazolderivate als oxytocinantagonisten
BRPI1013853A2 (pt) composições tópicas estáveis de derivados de 1,2,4-tiadiazol
CR10879A (es) Cyclized derivatives as eg-5 inhibitors
DK1885805T3 (da) Vandig overtrækssammensætning
BRPI0906357A2 (pt) Derivados de oxazepinopirimidona arilamida substituídos
ATE499367T1 (de) 1,3-dihydroimidazol-2-thionderivate als inhibitoren von dopamin-beta-hydroxylase
FR2902426B1 (fr) Derives de cinnamoyl-piperazine
FR2921232B1 (fr) Composition d'aerosol aqueuse
CU23857B1 (es) Nuevos derivados de benzamida como antagonistas de la bradiquinina
BRPI0924081A2 (pt) DERIVADOS DE 5- AMINO -2-(1-hIDROXI-ETIL)- TETRAHIDROPIRANO.
CR10809A (es) Derivados de heteroaril-pirrolidinil-y-piperidinil-cetona

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20150130